Therapy with Ulipristal Acetate in a Hypertensive Patient

Ulipristal acetate (UPA) is a medical therapy for patients with symptomatic uterine fibroids. The drug has shown efficacy in the control of heavy menstrual bleeding and, as a consequence, in anaemia improvement. We report the case of a hypertensive patient treated with two courses of UPA. In additio...

Descripción completa

Detalles Bibliográficos
Autores principales: Alcalde Dominguez, A., Rabasa Antonijuan, J., Cusidó Gimferrer, M., Ortuño, M. Jiménez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236705/
https://www.ncbi.nlm.nih.gov/pubmed/30515219
http://dx.doi.org/10.1155/2018/1091520
_version_ 1783371072990609408
author Alcalde Dominguez, A.
Rabasa Antonijuan, J.
Cusidó Gimferrer, M.
Ortuño, M. Jiménez
author_facet Alcalde Dominguez, A.
Rabasa Antonijuan, J.
Cusidó Gimferrer, M.
Ortuño, M. Jiménez
author_sort Alcalde Dominguez, A.
collection PubMed
description Ulipristal acetate (UPA) is a medical therapy for patients with symptomatic uterine fibroids. The drug has shown efficacy in the control of heavy menstrual bleeding and, as a consequence, in anaemia improvement. We report the case of a hypertensive patient treated with two courses of UPA. In addition to its observed benefits on hypermenorrhea caused by uterine fibroids, no exacerbation of the underlying disease was observed. No adverse effects were observed, and blood pressure levels were well controlled throughout.
format Online
Article
Text
id pubmed-6236705
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-62367052018-12-04 Therapy with Ulipristal Acetate in a Hypertensive Patient Alcalde Dominguez, A. Rabasa Antonijuan, J. Cusidó Gimferrer, M. Ortuño, M. Jiménez Case Rep Med Case Report Ulipristal acetate (UPA) is a medical therapy for patients with symptomatic uterine fibroids. The drug has shown efficacy in the control of heavy menstrual bleeding and, as a consequence, in anaemia improvement. We report the case of a hypertensive patient treated with two courses of UPA. In addition to its observed benefits on hypermenorrhea caused by uterine fibroids, no exacerbation of the underlying disease was observed. No adverse effects were observed, and blood pressure levels were well controlled throughout. Hindawi 2018-11-01 /pmc/articles/PMC6236705/ /pubmed/30515219 http://dx.doi.org/10.1155/2018/1091520 Text en Copyright © 2018 A. Alcalde Dominguez et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Alcalde Dominguez, A.
Rabasa Antonijuan, J.
Cusidó Gimferrer, M.
Ortuño, M. Jiménez
Therapy with Ulipristal Acetate in a Hypertensive Patient
title Therapy with Ulipristal Acetate in a Hypertensive Patient
title_full Therapy with Ulipristal Acetate in a Hypertensive Patient
title_fullStr Therapy with Ulipristal Acetate in a Hypertensive Patient
title_full_unstemmed Therapy with Ulipristal Acetate in a Hypertensive Patient
title_short Therapy with Ulipristal Acetate in a Hypertensive Patient
title_sort therapy with ulipristal acetate in a hypertensive patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236705/
https://www.ncbi.nlm.nih.gov/pubmed/30515219
http://dx.doi.org/10.1155/2018/1091520
work_keys_str_mv AT alcaldedomingueza therapywithulipristalacetateinahypertensivepatient
AT rabasaantonijuanj therapywithulipristalacetateinahypertensivepatient
AT cusidogimferrerm therapywithulipristalacetateinahypertensivepatient
AT ortunomjimenez therapywithulipristalacetateinahypertensivepatient

Ejemplares similares